Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DC3 Therapeutics is a private, active contract research organization based in South San Francisco that supports biotech and pharmaceutical clients across discovery, preclinical, IND-enabling, and selected clinical-stage laboratory activities. The company positions itself as a one-stop CRO offering cell and molecular biology, biochemical and cell-based assays, protein chemistry, histology, immunohistochemistry, spatial biology, biomarker analysis, and program management services. DC3 also operates a CLIA-certified, COLA-accredited laboratory and provides companion diagnostic support and custom lab-developed tests. Rather than advancing a proprietary therapeutic pipeline, the company provides integrated scientific services intended to accelerate client decision-making and regulatory readiness. Its business model is service-based and collaborative, acting as an extension of internal R&D teams for drug discovery and early development programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DC3 Therapeutics.